Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

2.3K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.3K
RNA Editing02:23

RNA Editing

8.8K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.8K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

5.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene Editing Strategies for Duchenne Muscular Dystrophy: From Molecular Mechanisms to Clinical Translation.

Cells·2026
Same author

Successful In Vitro Modification of the <i>Dmd</i> Gene Using Prime Editing.

Cells·2026
Same author

Asynchrony Related to Mechanical Ventilation Exacerbates Diaphragm Dysfunction in a Mouse Model of Duchenne Muscular Dystrophy.

Muscle & nerve·2026
Same author

Lifelong heat exposure as a potential contributor to Alzheimer's disease resilience.

Journal of Alzheimer's disease : JAD·2026
Same author

Molecular characterization of a new R1925X point mutation mouse model for dysferlinopathy.

Genes & diseases·2026
Same author

Regulatory Mechanisms of Lipid Rafts in Remodeling the Tumor Immune Microenvironment of Colorectal Cancer and Targeted Therapeutic Strategies.

Biomolecules·2025

Related Experiment Video

Updated: May 11, 2025

Functional Characterization of Endogenously Expressed Human RYR1 Variants
07:59

Functional Characterization of Endogenously Expressed Human RYR1 Variants

Published on: June 9, 2021

2.4K

Universal Prime Editing Therapeutic Strategy for RyR1-Related Myopathies: A Protective Mutation Rescues Leaky RyR1

Kelly Godbout1,2, Mathieu Dugas1,2, Steven R Reiken3

  • 1Molecular Medicine Department, Laval University, Quebec, QC G1V 0A6, Canada.

International Journal of Molecular Sciences
|April 17, 2025
PubMed
Summary

A new prime editing approach targets RyR1-related myopathies by introducing a protective S2843A mutation. This strategy stabilizes the RyR1 calcium channel, reducing calcium leaks and offering a potential universal treatment for these genetic muscle disorders.

Keywords:
CRISPR/Cas9RYR1 geneRyR1-RMcalcium channelcalcium leakprime editingprotective mutation

More Related Videos

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

6.1K
Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study
12:43

Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study

Published on: July 27, 2016

11.3K

Related Experiment Videos

Last Updated: May 11, 2025

Functional Characterization of Endogenously Expressed Human RYR1 Variants
07:59

Functional Characterization of Endogenously Expressed Human RYR1 Variants

Published on: June 9, 2021

2.4K
Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

6.1K
Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study
12:43

Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study

Published on: July 27, 2016

11.3K

Area of Science:

  • Genetics
  • Molecular Biology
  • Biochemistry

Background:

  • RyR1-related myopathies (RyR1-RMs) are genetic disorders caused by RYR1 gene mutations.
  • These mutations disrupt intracellular calcium homeostasis, leading to muscle dysfunction.
  • Stabilizing the RyR1 calcium channel to fix calcium leaks is a key therapeutic strategy.

Purpose of the Study:

  • To investigate the protective effect of the RyR1-S2843A mutation.
  • To evaluate the efficiency of prime editing in introducing this protective mutation.
  • To establish a foundation for a universal gene therapy for RyR1-RMs.

Main Methods:

  • Calcium leak assay to assess the S2843A mutation's effect.
  • Prime editing via RNA electroporation in human myoblasts.
  • In vitro experiments to determine mutation introduction efficiency.

Main Results:

  • The S2843A mutation significantly reduced RyR1 calcium channel leak.
  • Prime editing efficiently introduced the protective S2843A mutation in human myoblasts (31% efficiency).
  • The S2843A mutation showed protective effects when combined with pathogenic mutations.

Conclusions:

  • The S2843A mutation offers a protective mechanism against RyR1 calcium leak.
  • Prime editing is an effective tool for introducing therapeutic mutations in RYR1.
  • This study supports a potential universal prime editing treatment for RyR1-RMs.